The Patent Finder

Tact IP, LLC

Also on record
Records under this name other than the patents Tact IP, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Back to Tact IP, LLC

PatentTitleStatus Expires Confidence
US 6,641,944Fuel Cell Drive System
Term ended
Term ended Apr 19, 2022 · High confidence
Term endedTerm ended Apr 19, 2022High confidence
US 8,119,127Cytokine antagonists for neurological and neuropsychiatric disorders
Term ended
Term ended Jan 16, 2020 · From the USPTO record
Term endedTerm ended Jan 16, 2020From the USPTO record
US 6,177,077TNT inhibitors for the treatment of neurological disorders
Term ended
Term ended Dec 31, 2019 · From the USPTO record
Term endedTerm ended Dec 31, 2019From the USPTO record
US 7,214,658Method of delivering a TNF antagonist to the brain of a human by perispinal administration without direct intrathecal injection
Lapsed on the fee record
Ended May 8, 2019 · From the USPTO record
Lapsed on the fee recordEnded May 8, 2019From the USPTO record
US 6,419,944Cytokine antagonists for the treatment of localized disorders
Term ended
Ended no later than Feb 24, 2019 · From the USPTO record
Term endedEnded no later than Feb 24, 2019From the USPTO record
US 6,537,549Cytokine antagonists for the treatment of localized disorders
Term ended
Ended no later than Feb 24, 2019 · From the USPTO record
Term endedEnded no later than Feb 24, 2019From the USPTO record
US 6,982,089Cytokine antagonists for neurological and neuropsychiatric disorders
Term ended
Ended no later than Feb 24, 2019 · From the USPTO record
Term endedEnded no later than Feb 24, 2019From the USPTO record
US 7,629,311Methods to facilitate transmission of large molecules across the blood-brain, blood-eye, and blood-nerve barriers
Term ended
Ended no later than Feb 24, 2019 · From the USPTO record
Term endedEnded no later than Feb 24, 2019From the USPTO record
US 8,236,306Methods to facilitate transmission of large molecules across the blood-brain, blood-eye, and blood-nerve barriers
Term ended
Ended no later than Feb 24, 2019 · From the USPTO record
Term endedEnded no later than Feb 24, 2019From the USPTO record
US 8,349,323Cytokine antagonists for neurological and neuropsychiatric disorders
Term ended
Ended no later than Feb 24, 2019 · From the USPTO record
Term endedEnded no later than Feb 24, 2019From the USPTO record
10 of 18 patents shown.
Pro members see all 18.
Pro members: see all 18 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited